Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Receivables: 2017-2025

Historic Receivables for Organogenesis Holdings (ORGO) over the last 7 years, with Sep 2025 value amounting to $182.2 million.

  • Organogenesis Holdings' Receivables rose 64.16% to $182.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $545.6 million, marking a year-over-year increase of 30.54%. This contributed to the annual value of $119.4 million for FY2024, which is 34.41% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Receivables stood at $182.2 million, which was up 38.54% from $131.5 million recorded in Q2 2025.
  • Organogenesis Holdings' Receivables' 5-year high stood at $182.2 million during Q3 2025, with a 5-year trough of $78.1 million in Q1 2021.
  • Its 3-year average for Receivables is $114.5 million, with a median of $111.0 million in 2024.
  • Its Receivables has fluctuated over the past 5 years, first skyrocketed by 117.32% in 2021, then declined by 7.26% in 2023.
  • Over the past 5 years, Organogenesis Holdings' Receivables (Quarterly) stood at $87.6 million in 2021, then rose by 9.36% to $95.8 million in 2022, then decreased by 7.26% to $88.9 million in 2023, then surged by 34.41% to $119.4 million in 2024, then soared by 64.16% to $182.2 million in 2025.
  • Its Receivables stands at $182.2 million for Q3 2025, versus $131.5 million for Q2 2025 and $112.4 million for Q1 2025.